How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval
PharmaTalkRadio2 Des 2019

How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval

In this session recorded at the 7th annual Chief Medical Officer Summit, Dr Steve Kanes, Chief Medical Officer, Sage Therapeutics, discusses how a company considered as an "up and comer" in the Cambridge biotech sector navigated the development and approval of the first treatment specifically designed for postpartum depression. Learn more at theconferenceforum.org

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
sinnsyn
rss-nysgjerrige-norge
forskningno
dekodet-2
liberal-halvtime
rekommandert
rss-paradigmepodden
fjellsportpodden
rss-rekommandert
tidlose-historier
villmarksliv
jss
grunnstoffene
hva-er-greia-med
rss-bondevennen
tomprat-med-gunnar-tjomlid
nordnorsk-historie